Primary and secondary outcomes for sexual and intravenous drug behaviour change interventions
| Study | Outcome | OR or SMD |
| (95% CI) | ||
| Primary outcomes | ||
| Iguchi95 | Acquisition of HIV | OR 0.37 (0.11 to 1.28) |
| Secondary outcomes | ||
| Avants96 | Number of weeks had sex without a condom | SMD −0.326 (−0.594 to −0.059) |
| Cottler97 | No sex if no condom | OR 0.99 (0.70 to 1.40) |
| Cottler97 | Used a condom in the last 30 days | OR 1.01 (0.74 to 1.36) |
| Cottler97 | ‘Improved’ condom use | OR 1.31 (0.98 to 1.77) |
| Eldridge98 | Log mean proportion of vaginal sex protected | SMD 0.925 (0.356 to 1.494) |
| Kotranski99 | 100% condom use or abstinence (vaginal or unspecified) | OR 1.50 (1.02 to 2.22) |
| Cottler97 | 100% condom use (vaginal or unspecified) | OR 0.95 (0.66 to 1.37) |
| Margolin100 | 100% condom use (vaginal or unspecified) | OR 3.94 (0.94 to 16.58) |
| Hershberger101 | 100% condom use (vaginal or unspecified) | OR 2.43 (1.37 to 4.32) |
| Hershberger101 | Proportion of sex protected (vaginal or unspecified) | SMD 0.08 (−0.07 to 0.22) |
| Iguchi95 | Improvement in condom use (dichotomous) | OR 1.03 (0.76 to 1.40) |
| Sorensen102 (maintenance group) | Proportion of sex protected (vaginal or unspecified) | SMD 0.661 (−0.397 to 1.718) |
| Sorensen102 (detoxification group) | Proportion of sex protected (vaginal or unspecified) | SMD 0.031 (−0.737 to 0.800) |